Chloroquine, sulfadoxine-pyrimethamine and amodiaquine efficacy for the treatment of uncomplicated Plasmodium falciparum malaria in Upper Nile, South Sudan

This publication has 17 references indexed in Scilit:

• Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment ofPlasmodium falciparumMalaria
  The Journal of Infectious Diseases, 2002
• Modelling parasite drug resistance: lessons for management and control strategies
  Tropical Medicine & International Health, 2001
• Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania
  The Lancet, 2001
• Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 2001
• In vivoefficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania
  Tropical Medicine & International Health, 2000
• Molecular Evidence of Greater Selective Pressure for Drug Resistance Exerted by the Long‐Acting Antifolate Pyrimethamine/Sulfadoxine Compared with the Shorter‐Acting Chlorproguanil/Dapsone on KenyanPlasmodium falciparum
  The Journal of Infectious Diseases, 2000
• Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum : Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites
  Antimicrobial Agents and Chemotherapy, 2000
• The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya.
  The American Journal of Tropical Medicine and Hygiene, 2000
• Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan Africa
  Tropical Medicine & International Health, 1998
• Systematic review of amodiaquine treatment in uncomplicated malaria
  The Lancet, 1996